Icotinib is an active treatment of non-small-cell lung cancer: a retrospective study.

Icotinib is an active treatment of non-small-cell lung cancer: a retrospective study.

Icotinib hydrochloride is a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with preclinical and clinical activity in non-small cell lung cancer (NSCLC). This retrospective analysis was performed to assess the efficacy of icotinib on patients with non-small-cell lung ca...

Full description

Bibliographic Details
Main Authors: Xiaofeng Chen, Quan Zhu, Yiqian Liu, Ping Liu, Yongmei Yin, Renhua Guo, Kaihua Lu, Yanhong Gu, Lianke Liu, Jinghua Wang, Zhaoxia Wang, Oluf Dimitri Røe, Yongqian Shu, Lingjun Zhu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4023939?pdf=render

Internet

http://europepmc.org/articles/PMC4023939?pdf=render

Similar Items